MTHFR C677T polymorphisms are associated with aberrant methylation of the IGF-2 gene in transitional cell carcinoma of the bladder

Journal of Biomedical Research - Tập 26 - Trang 77-83 - 2012
Huan Cheng1, Zhonglei Deng1, Zengjun Wang1, Wei Zhang1, Jiantang Su1
1Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, China

Tài liệu tham khảo

Marsit, 2010, Identification of meth-ylated genes associated with aggressive bladder cancer, PLoS One, 5, e12334, 10.1371/journal.pone.0012334 Vikram, 2009, Imaging and staging of transitional cell carcinoma: part 1, lower urinary tract, AJR Am J Roentgenol, 192, 1481, 10.2214/AJR.08.1318 Hansen, 1988, Tumor suppressors: recessive mutations that lead to cancer, Cell, 53, 173, 10.1016/0092-8674(88)90376-5 Hunter, 1997, Oncoprotein networks, Cell, 88, 333, 10.1016/S0092-8674(00)81872-3 Jones, 2007, The epigenomics of cancer, Cell, 128, 683, 10.1016/j.cell.2007.01.029 Fang, 2006, Regulation of hMSH2 and hMLH1 expression in the human colon cancer cell line SW1116 by DNA methyltransferase 1, Cancer Lett, 233, 124, 10.1016/j.canlet.2005.03.005 Tada, 2011, Aberrant DNA methylation of T-cell leukemia, homeobox 3 modulates cisplatin sensitivity in bladder cancer, Int J Oncol, 39, 727 Brait, 2011, Cancer epigenetics: above and be-yond, Toxicol Mech Methods, 21, 275, 10.3109/15376516.2011.562671 Eze, 2011, The role of epigenetic alterations in papillary thyroid carcinogenesis, J Thyroid Res, 2011, 895470, 10.4061/2011/895470 Choi, 2007, Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors), Mod Pathol, 20, 802, 10.1038/modpathol.3800825 Gonzalo, 2008, Epigenetics of cancer, Gastroenterol Hepatol, 31, 37, 10.1157/13114573 Oyama, 2004, The association between methylenetetrahydro-folate reductase polymorphism and promoter methylation in proximal colon cancer, Anticancer Res, 24, 649 Batra, 2007, Modulation of DNA methyltrans-ferase profile by methyl donor starvation followed by gamma irradiation, Mol Cell Biochem, 294, 181, 10.1007/s11010-006-9258-8 Zhu, 2011, Overex-pression of MBD2 in Glioblastoma Maintains Epigenetic Silencing and Inhibits the Antiangiogenic Function of the Tumor Suppressor Gene BAI1, Cancer Res, 71, 5859, 10.1158/0008-5472.CAN-11-1157 Huang, 2006, DNA methylation, riboswitches, and transcription factor activity: fundamental mechanisms of gene-nutrient interactions involving vitamins, Mol Biol Rep, 33, 253, 10.1007/s11033-006-9005-y Milutinovic, 2007, Val-proate induces widespread epigenetic reprogramming which involves demethylation of specific genes, Carcinogenesis, 28, 560, 10.1093/carcin/bgl167 Nicholson, 2008, Spatial and temporal con-trol of gene expression in Drosophila using the inducible GeneSwitch GAL4 system. I. Screen for larval nervous system drivers, Genetics, 178, 215, 10.1534/genetics.107.081968 Chalitchagorn, 2004, Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis, Oncogene, 23, 8841, 10.1038/sj.onc.1208137 Fraga, 2007, Cross-talk between aging and cancer: the epigenetic language, Ann N Y Acad Sci, 1100, 60, 10.1196/annals.1395.005 Lu, 2006, The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer, Clin Cancer Res, 12, 1208, 10.1158/1078-0432.CCR-05-1801 Elzagheid, 2006, Lymph node status as a guide to selection of available prognos-tic markers in breast cancer: the clinical practice of the future?, Diagn Pathol, 1, 41, 10.1186/1746-1596-1-41 Murrell, 2008, Distinct methylation changes at the IGF2-H19 locus in congenital growth disorders and can-cer, PLoS One, 3, e1849, 10.1371/journal.pone.0001849 Cui, 2003, Loss of IGF2 im-printing: a potential marker of colorectal cancer risk, Science, 299, 1753, 10.1126/science.1080902 Feil, 1994, Methylation analysis on individual chromosomes: improved pro-tocol for bisulphite genomic sequencing, Nucleic Acids Res, 22, 695, 10.1093/nar/22.4.695 Byun, 2007, Examination of IGF2 and H19 loss of imprinting in bladder cancer, Cancer Res, 67, 10753, 10.1158/0008-5472.CAN-07-0329 Liu, 2008, Gene-environment interactions and epigenetic basis of human diseases, Curr Issues Mol Biol, 10, 25 Feinberg, 2004, The epigenetics of cancer etiology, Semin Cancer Biol, 14, 427, 10.1016/j.semcancer.2004.06.005 Zhang, 2011, Dietary patterns are associated with levels of global genomic DNA methylation in a cancer-free population, J Nutr, 141, 1165, 10.3945/jn.110.134536 Friso, 2005, The MTHFR 1298A>C polymorphism and genomic DNA methylation in human lymphocytes, Cancer Epidemiol Biomarkers Prev, 14, 938, 10.1158/1055-9965.EPI-04-0601 Cellarier, 2003, Methionine dependency and cancer treatment, Cancer Treat Rev, 29, 489, 10.1016/S0305-7372(03)00118-X Weisberg, 1998, A second genetic polymorphism in methylenetetrahy-drofolate reductase (MTHFR) associated with decreased enzyme activity, Mol Genet Metab, 64, 169, 10.1006/mgme.1998.2714 Axume, 2007, The MTHFR 677TT genotype and folate intake interact to lower global leukocyte DNA methylation in young Mexican American women, Nutr Res, 27, 1317, 10.1016/j.nutres.2006.12.006 Supic, 2011, In-teraction between the MTHFR C677T polymorphism and alcohol–impact on oral cancer risk and multiple DNA methylation of tumor-related genes, J Dent Res, 90, 65, 10.1177/0022034510385243 Ma, 1997, Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorec-tal cancer, Cancer Res, 57, 1098 Yang, 2005, Gene-environment interactions between alcohol drinking and the MTHFR C677T polymorphism impact on esophageal cancer risk: results of a case-con-trol study in Japan, Carcinogenesis, 26, 1285, 10.1093/carcin/bgi076 Wang, 2005, Association of methylenetetrahydrofolate reductase and thymidylate synthase promoter polymorphisms with genetic susceptibility to esophageal and cardia cancer in a Chinese high-risk population, Dis Esophagus, 18, 177, 10.1111/j.1442-2050.2005.00492.x